Skip to main content
TipRanks
Go Ultimate75% OFF

Avalo Therapeutics (AVTX) Ratios

1,100 Followers

Avalo Therapeutics Ratios

AVTX's free cash flow for Q3 2026 was $-11.54M. For the 2026 fiscal year, AVTX's free cash flow was increased by $0.00 and operating cash flow was $-11.54M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio8.1419.961.820.743.11
Quick Ratio8.1419.961.820.743.11
Cash Ratio1.2319.331.610.602.74
Solvency Ratio-2.33-1.98-2.29-0.94-1.45
Operating Cash Flow Ratio-3.98-7.05-6.64-1.21-3.56
Short-Term Operating Cash Flow Coverage0.000.000.00-4.510.00
Net Current Asset Value$ 71.88M$ 121.19M$ -5.29M$ -27.87M$ 4.71M
Leverage Ratios
Debt-to-Assets Ratio0.020.000.030.600.42
Debt-to-Equity Ratio0.030.000.07-1.831.44
Debt-to-Capital Ratio0.030.000.072.210.59
Long-Term Debt-to-Capital Ratio0.020.000.005.250.59
Financial Leverage Ratio1.401.132.87-3.063.48
Debt Service Coverage Ratio0.000.00-6.82-3.69-33.58
Interest Coverage Ratio0.000.00-8.00-8.98-34.35
Debt to Market Cap0.010.000.000.410.19
Interest Debt Per Share0.180.0714.24615.22986.68
Net Debt to EBITDA0.173.840.30-0.180.26
Profitability Margins
Gross Profit Margin100.00%182.99%33.26%80.98%72.38%
EBIT Margin-132362.71%-7939.91%-1218.50%-207.41%-1521.56%
EBITDA Margin-131779.66%-7901.59%-1210.29%-206.49%-1490.87%
Operating Profit Margin-123601.69%-15535.60%-1421.57%-207.41%-1521.56%
Pretax Profit Margin-132362.71%-7939.91%-1638.77%-230.62%-1566.23%
Net Profit Margin-132642.37%-7965.76%-1639.50%-230.78%-1563.10%
Continuous Operations Profit Margin-132642.37%-7965.76%-1639.50%-230.78%-1562.60%
Net Income Per EBT100.21%100.33%100.04%100.07%99.80%
EBT Per EBIT107.09%51.11%115.28%111.19%102.94%
Return on Assets (ROA)-67.20%-23.31%-150.26%-124.85%-105.19%
Return on Equity (ROE)-94.23%-26.41%-431.87%381.66%-365.55%
Return on Capital Employed (ROCE)-70.45%-47.65%-167.03%-332.71%-136.15%
Return on Invested Capital (ROIC)-70.18%-47.47%-161.73%-211.35%-134.75%
Return on Tangible Assets-73.86%-25.05%-300.68%-219.74%-128.30%
Earnings Yield-32.15%-58.17%-1248.12%-87.85%-47.62%
Efficiency Ratios
Receivables Turnover0.000.7214.159.411.12
Payables Turnover0.00-1.292.881.190.44
Inventory Turnover0.000.000.00171.7039.24
Fixed Asset Turnover0.130.360.987.492.00
Asset Turnover0.000.000.090.540.07
Working Capital Turnover Ratio0.000.01-2.001.000.20
Cash Conversion Cycle0.00787.93-100.98-265.40-490.94
Days of Sales Outstanding0.00505.7025.8038.80324.50
Days of Inventory Outstanding0.000.000.002.139.30
Days of Payables Outstanding0.00-282.23126.78306.33824.74
Operating Cycle0.00505.7025.8040.93333.80
Cash Flow Ratios
Operating Cash Flow Per Share-3.84-6.04-110.47-682.39-1958.83
Free Cash Flow Per Share-3.84-6.04-111.04-684.81-1961.95
Dividend Paid and CapEx Coverage Ratio0.000.00-194.18-281.59-627.36
Capital Expenditure Coverage Ratio0.000.00-194.18-281.59-627.36
Operating Cash Flow Coverage Ratio-21.20-86.37-57.13-1.34-2.13
Operating Cash Flow to Sales Ratio-872.17-111.24-15.95-1.48-13.13
Free Cash Flow Yield-21.14%-81.23%-1220.19%-56.61%-40.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.11-1.72-0.08-1.14-2.10
Price-to-Sales (P/S) Ratio4125.96136.951.312.6332.83
Price-to-Book (P/B) Ratio2.930.450.35-4.347.68
Price-to-Free Cash Flow (P/FCF) Ratio-4.73-1.23-0.08-1.77-2.50
Price-to-Operating Cash Flow Ratio-4.73-1.23-0.08-1.77-2.50
Price-to-Earnings Growth (PEG) Ratio-0.090.020.000.020.27
Enterprise Value Multiple-2.962.110.19-1.45-1.94
Enterprise Value230.00M-73.58M-4.35M54.19M155.92M
EV to EBITDA-2.962.110.19-1.45-1.94
EV to Sales3898.32-166.86-2.263.0028.89
EV to Free Cash Flow-4.471.500.14-2.02-2.20
EV to Operating Cash Flow-4.471.500.14-2.03-2.20
Tangible Book Value Per Share5.4115.07-11.51-645.99238.60
Shareholders’ Equity Per Share6.2016.3726.30-278.43637.78
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.00-0.000.00
Revenue Per Share0.000.056.93460.46149.15
Net Income Per Share-5.84-4.32-113.58-1062.65-2331.41
Tax Burden1.001.001.001.001.00
Interest Burden1.001.001.341.111.03
Research & Development to Revenue848.88118.097.161.7311.08
SG&A to Revenue388.1439.105.341.144.26
Stock-Based Compensation to Revenue230.8613.271.810.421.51
Income Quality0.661.400.970.640.84

Currency in USD